British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.

Journal: Journal of psychopharmacology (Oxford, England)

Volume: 31

Issue: 5

Year of Publication: 2018

Affiliated Institutions:  Institute of Neuroscience, Newcastle University, Newcastle, UK. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. NHS Greater Glasgow and Clyde, Glasgow, UK. Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK. Institute of Reproductive and Developmental Biology, Imperial College London, London, UK. Ealing, Hounslow, Hammersmith & Fulham Perinatal Mental Health Service, West London Mental Health Trust, London, UK. Section of Women's Mental Health, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK. National Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. Centre for Psychiatry, Imperial College London, London, UK. Royal College of Psychiatrists, London, UK. Behavioural and Brain Sciences Unit, GOSH Institute of Child Health, University College London, London, UK. South London and Maudsley NHS Foundation Trust, London, UK. St Martin's Healthcare Services CIC, Leeds, UK. Tees, Esk and Wear Valleys NHS Foundation Trust, Darlington, County Durham, UK. Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK. UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Abstract summary 

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.

Authors & Co-authors:  McAllister-Williams R Hamish RH Baldwin David S DS Cantwell Roch R Easter Abby A Gilvarry Eilish E Glover Vivette V Green Lucian L Gregoire Alain A Howard Louise M LM Jones Ian I Khalifeh Hind H Lingford-Hughes Anne A McDonald Elizabeth E Micali Nadia N Pariante Carmine M CM Peters Lesley L Roberts Ann A Smith Natalie C NC Taylor David D Wieck Angelika A Yates Laura M LM Young Allan H AH

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  23
Identifiers
Doi : 10.1177/0269881117699361
SSN : 1461-7285
Study Population
Women,Female
Mesh Terms
Female
Other Terms
Antidepressants;antipsychotics;anxiolytics;birth defects;breastfeeding;child development;conception;fertility;hypnotics;mood stabilisers;neonatal problems;postpartum;pregnancy;pregnancy outcome;psychiatric illness;psychotropics;teratogenicity
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
United States